Decision Diagnostics Corp (DECN)

[vinovista]

HHS said in a statement that as part of the new program, government health experts will conduct studies on over-the-counter tests and work with the companies “to compile proper data, work towards the right benchmarks for performance and support other needs that will help ensure they are providing the best submissions possible for FDA’s regulatory review.”

The U.S. Food and Drug Administration is streamlining its authorization process, while the National Institutes of Health will spend $70 million on a new program to accelerate test-makers through those regulatory hurdles. The funds will come from the American Rescue Plan, the $1.9 trillion Covid relief package President Joe Biden signed into law in March.